Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Yellow Fever Vaccine Market Size Shifted, And What Is the Outlook Through 2034?
The market size for the yellow fever vaccine has been experiencing consistent growth over the past few years. The figure is expected to rise from $4.54 billion in 2024 to $4.74 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. The historical growth rate is a direct result of the launching of worldwide immunization campaigns, the enforcement of international health regulations, large-scale vaccination initiatives, and technological advancements in vaccine production.
Projected expansion for the yellow fever vaccine market is estimated to be quite stable in the coming years, reaching a value of $5.66 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The predicted growth during this period is likely due to increased engagement in collaborations and partnerships, the integration of routine vaccination timetables, vigilant surveillance and monitoring, growing contribution from the private sector, and the implementation of digital tracking for vaccines. Key anticipated trends in this timeframe include the evolution of vaccine formats, readiness for potential pandemics, changes in regulation, enhancements to healthcare infrastructure, and ongoing efforts to educate and raise consumer awareness.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp
Which Primay Drivers Are Accelerating Growth in the Yellow Fever Vaccine Market?
The expansion of the yellow fever vaccine market is anticipated to be fuelled by the growth in international travel. When people move across frontier for leisure, business, or personal motivations, this is referred to as international travel. Economic growth, increased global interconnection, and eased travel constraints post-pandemic contribute to the escalation in international travel. Travellers intending to visit regions where yellow fever is prevalent are either required or recommended to get the yellow fever vaccine as a preventive measure against the disease and to adhere to international health policies. For example, the World Tourism Organization, a Spain-based entity, stated in January 2024 that there were 1.286 billion international overnight visitors globally in 2023, up from 960 million such visitors in 2022. This represents a rise of 326 million international tourists between 2022 and 2023. Thus, the uptick in international travel is contributing to the growth of the yellow fever vaccine market.
Which Primary Segments of the Yellow Fever Vaccine Market Are Driving Growth and Industry Transformations?
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Yellow Fever Vaccine Market?# Market?
North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Yellow Fever Vaccine Industry Dynamics?
Leading entities in the yellow fever vaccine industry are turning their attention to engineering advanced yellow fever vaccines, like the T-cell adaptive booster vaccine, in a bid to cater to the growing worldwide demand for such vaccines. The T-cell adaptive booster vaccine is an innovative vaccination style aimed at upgrading the memory T-cell reaction of the immune system, establishing lasting and powerful resistance against particular pathogens. To illustrate, Emergex Vaccines Holding Limited, a biotechnology firm rooted in the UK, joined forces with ATCC in April 2022. ATCC is a US-based not-for-profit entity that supplies reference microorganisms, cell lines, and other materials for research and progress. They launched CD8+ T-cell adaptive vaccines that target yellow fever specifically. These vaccines intend to provoke a strong cytotoxic T-cell response crucial for spotting and ridding of cells infected with viruses. By enhancing the creation of memory CD8+ T-cells, these vaccines enable lasting and powerful immunity. They target the cellular immune response rather than focusing solely on producing antibodies, resulting in all-encompassing protection from yellow fever and potentially escalating effectiveness in distinct immune profiles.
View the full report here:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
What Parameters Are Used to Define the Yellow Fever Vaccine Market?
The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17297
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
